Edwards Lifesciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
EW Key Statistics
Stock Snapshot
As of today, Edwards Lifesciences(EW) shares are valued at $83.16. The company's market cap stands at 47.95B, with a P/E ratio of 45.20.
On 2026-05-07, Edwards Lifesciences(EW) stock traded between a low of $83.01 and a high of $84.43. Shares are currently priced at $83.16, which is +0.2% above the low and -1.5% below the high.
The Edwards Lifesciences(EW)'s current trading volume is 1.29M, compared to an average daily volume of 6.1M.
During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $87.89 at its peak.
During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $87.89 at its peak.
EW News
If you are wondering whether Edwards Lifesciences at around US$83.20 still offers value, the key question is how its current price stacks up against what the bu...
(RTTNews) - Edwards Lifesciences Corporation (EW) said that it has appointed Theodora Mistras as chief financial officer effective at the end of May. Mistras w...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
76%
of 34 ratingsMore EW News
Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on Edwards Lifesciences. The associated price target remains the same with $97.00. Unlock he...
Edwards Lifesciences (EW) announced 10-year results from the Commence aortic trial, reinforcing the long-term durability and sustained performance of its propri...
Edwards Lifesciences recently reported 10‑year results from its COMMENCE aortic trial, showing high freedom from valve deterioration and reoperation for patient...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.